The effects of clonazepam on quality of life and work productivity in panic disorder

American Journal of Managed Care

Volumn 3, Issue 8, 1997, Pages 1187-1196

  Jacobs, R Jake ^a,d   Davidson, Jonathan R T ^b   Gupta, Sanjay ^c   Meyerhoff, Allen S ^a  

^a Capital Outcomes Research Inc   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

^d Capitol Outcomes Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CLONAZEPAM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; EMPLOYMENT; FEMALE; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PANIC; PRODUCTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; WORKLOAD;

ADULT; CLONAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; EFFICIENCY; EMPLOYMENT; FEMALE; GABA MODULATORS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PANIC DISORDER; QUALITY OF LIFE; WORKLOAD;

EID: 0031203010     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Markowitz JS, Weissman MM, Ouellette R, et al. Quality of life in panic disorder. Arch Gen Psychiatry 1989;46: 984-992.
2. Edlund MJ, Swann AV. The economic and social costs of panic disorder. Hosp Community Psychiatry 1987;38: 1277-1279, 1288.
3. Taylor CB, King R, Margraf J, et al. Use of medication and in vivo exposure in volunteers for panic disorder research. Am J Psychiatry 1989;146:1423-1426.
4. Weissman MM, Markowitz JS, Ouellette R. Panic disorder and cardiovascular/cerebrovascular problems: Results from a community survey. Am J Psychiatry 1990; 147: 1504-1508.
5. Katon WJ, Von Korff M, Lin E. Panic disorder: Relationship to high medical utilization. Am J Med 1992;92 (suppl 1A):7S-11S.
6. Chignon JM, Lepine JP, Ades J. Panic disorder and alcoholism. Encephale 1991;17:519-523.
7. Massion AO, Warshaw MG, Keller MB. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry 1993;150:600-607.
8. Sherbourne CD, Wells KB, Judd LL. Functioning and well-being of patients with panic disorder. Am J Psychiatry 1996;153:213-218.
9. Katon WJ, Hollifield M, Chapman T, et al. Infrequent panic attacks: Psychiatric comorbidity, personality characteristics and functional disability. J Psychiatr Res 1995;29: 121-131.
10. Ettigi P, Meyerhoff AS, Chirban JT, et al. Quality of life and employment in panic disorder. J Nerv Ment Dis 1997; 185:368-372.
11. Weissman MM, Kerman GL, Markowitz JS, Ouellette R. Suicide ideation and suicide attempts in panic disorder and attacks. JAMA 1989;321:1209-1214.
12. Coryell W, Noyes R, Clancy J. Excess mortality in panic disorder. A comparison with primary unipolar depression. Arch Gen Psychiatry 1982;39:701-703.
13. Allgulander C, Lavori PW. Excess mortality among 3302 patients with "pure" anxiety neurosis. Arch Gen Psychiatry 1991;48:599-602.
14. Hornig CD, McNally RJ. Panic disorder and suicide attempt. A reanalysis of data from the Epidemiologic Catchment Area study. Br J Psychiatry 1995;167:76-79.
15. Hollander E, Simeon D, Gorman JM. Anxiety disorders. In: Hales RE, Yudofsky SC, Talbott JA, eds. American Psychiatric Press Textbook of Psychiatry. Washington, DC: American Psychiatric Press; 1994:495-520.
16. Moroz G, Rosenbaum JF. Clonazepam efficacy in the treatment of panic disorder: Results of a multicenter placebo-controlled trial. Presented at the American Psychiatric Association annual meeting; May 4, 1996; New York, NY.
17. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Press; 1987.
18. Stein MB, Hazen AL, Eldridge GD, Walker JR. Structured Clinical Interview for DSM-III-R, Revised for Use in Hoffmann-La Roche Anxiety Disorders Program. Version 2.1. Winnipeg, Canada: University of Manitoba; 1992.
19. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36), I: Conceptual framework and item selection. Med Care 1992;30:473-483.
20. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short form health survey (SF-36), II: Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
21. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: A new outcome measure for primary care. Br Med J 1992;305:160-164.
22. McHorney CA, Ware JE, Rogers W, et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992;30(suppl): MS253-MS265.
23. Chirban JT, Jacobs RJ, Warren J, et al. The 36-item short form health survey (SF-36) and work productivity and impairment (WPAI) questionnaire in panic disorder. Dis Management Health Outcomes 1997;1:154-164.
24. Reilly MC, Zbrozek AS, Duke EM. The validity and reproducibility of a work productivity and impairment instrument. Pharmacoeconomics 1993;4:353-365.
25. Ware JE. Standards for validating health measures: Definition and content. J Chronic Dis 1987;40:473-480.
26. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute; 1994.
27. Ware JE, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of the SF-36 health profile and summary measures: A summary of results from the Medical Outcome Study. Med Care 1995;33(suppl 4):AS264-AS279.
28. Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996;275:1 897-1902.
29. Phillips RC, Lansky DJ. Outcomes management in heart valve replacement surgery: Early experience. J Heart Valve Dis 1992;1:42-50.
30. Katz JN, Larson MG, Phillips CB, et al. Comparative measurement sensitivity of short and longer health status instruments. J Rheumatol 1992;19:1938-1942.
31. Lansky D, Butler JBV, Waller FT. Using health status measures in the hospital setting: From acute care to outcomes management. Med Care 1992;30(suppl):MS57-MS73.